Evaluation of Xpert® MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine Trial

Erick Wekesa Bunyasi(South African Tuberculosis Vaccine Initiative), Mark Hatherill(South African Tuberculosis Vaccine Initiative)

PLoS ONE

November 10, 2015

10.1371/journal.pone.0141623

Cited by 27

Related Papers

Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial

|Gates Open Research|2017|45